Jazz Pharmaceuticals, Inc.
Menlo Park, CA
- UEI
- H9AXCNRA5NE6
- CAGE
- 4RTH5
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 2 El Camino Real, Menlo Park, CA 94025, USA
- Website
- jazzpharma.com
- Founded
- 2005
- Employees
- 1K-5K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $446,315 |
| FY2025 | $1,978,420 |
| FY2024 | $2,185,359 |
| FY2023 | $1,119,755 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $446,315 |
Contract vehicles
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Amneal Pharmaceuticals Of New York, LLC | Medford, NY | 325412 Pharmaceutical Preparation Manufacturing |
| Ardelyx, Inc. | Waltham, MA | 325412 Pharmaceutical Preparation Manufacturing |
| Hygen Pharmaceuticals Inc. | Redmond, WA | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| Dompe U.s. Inc. | San Mateo, CA | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| Cosette Pharmaceuticals, Inc. | Bridgewater Township, NJ | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Jazz Pharmaceuticals, Inc., headquartered in Menlo Park, California, manufactures and supplies specialty pharmaceutical products to the Department of Veterans Affairs as a prime contractor on a full-and-open, unrestricted-competition basis, with no SBA set-asides across its federal footprint.
Jazz Pharmaceuticals operates exclusively as a prime contractor (100% of recent awards) and serves the VA across 18 distinct customer agencies, predominantly through Veterans Integrated Service Networks. The company's federal capability is narrowly focused: manufacturing and distributing Xyrem (sodium oxybate) and Xywav (calcium/magnesium/potassium/sodium oxybate), specialty medications for treating narcolepsy and sleep disorders in veteran populations. Representative recent awards include a $397,859.12 delivery order from VISN 20 (February 2026) for Xywav 500mg/ml oral solution, a $678,610.27 delivery order from VISN 20 (June 2025) for bulk Xywav, and a $526,119.43 delivery order from VISN 20 (December 2024) for bulk pharmacy Xywav. All work is performed at Jazz's facility in Normandy, Missouri, or at Palo Alto, California.
Customer concentration is extreme and singular. The Department of Veterans Affairs accounts for 100% of awards across all customer rankings. Within VA, concentration is further compressed: VISN 12 anchors 97% of combined potential value (976.3 million dollars) on just 15 awards, while the VA's National Acquisition Center carries a second-tier $311.2 million across 3 awards (the parent single-award BPA). The top five VISNs by award count (VISN 6, 4, 21, 5, and 20) account for 64% of awards but carry only small per-order values—typically $10,000 to $35,000 per delivery order. This divergence signals that VISN 12's large-dollar awards are the financial anchor; the many smaller VISNs place routine, low-dollar replenishment orders.
Jazz Pharmaceuticals holds a single parent vehicle: the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) issued by GSA. Against this schedule, the company maintains a single-award Blanket Purchase Agreement with the VA's National Acquisition Center, valued at $161,183,457.45 and expiring August 15, 2027, established August 16, 2024. The BPA authorizes procurement of Xyrem and Xywav across multiple VISNs and sites including Normandy and Palo Alto, California, and St. Louis, Missouri. Task orders under the FSS-61-IB total 323 orders with $337 million in combined potential value.
Award activity has grown sharply in the past two years—from 1 award in 2022 to 12 in 2023 to 40 in 2024—before falling to 7 in 2025 and 2 in early 2026. This recent slowdown warrants attention: only 3 awards (combined potential value $897 thousand) are reaching ultimate completion within the next twenty-four months, indicating minimal near-term recompete exposure. However, the steep decline in 2025–2026 activity suggests pipeline constraint or customer consolidation of orders under the existing BPA.
The vendor operates entirely as a manufacturer and has no identified subcontracting relationships in the source data. Jazz Pharmaceuticals competes without set-asides and without small business preferences, positioning itself as the VA's primary supplier for oxybate-based sleep disorder medications through established schedule and BPA vehicles.
Quick answers
Is Jazz Pharmaceuticals, Inc. registered in SAM.gov?
Yes. Jazz Pharmaceuticals, Inc.'s SAM.gov registration is active through December 26, 2026.
Which contract vehicles does Jazz Pharmaceuticals, Inc. hold?
Jazz Pharmaceuticals, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
How much has Jazz Pharmaceuticals, Inc. received in federal contracts?
Federal contracts obligated $1,978,420 to Jazz Pharmaceuticals, Inc. in fiscal year 2025 and $5,729,850 in fiscal years 2023 through 2027.
How does Jazz Pharmaceuticals, Inc. rank among federal contractors?
Jazz Pharmaceuticals, Inc. ranked #49 in NAICS 325412, #64 in PSC 6505 and #76 in NAICS 3254 in FY2025.
What is Jazz Pharmaceuticals, Inc.'s most recent federal award?
Jazz Pharmaceuticals, Inc.'s most recent federal contract award is Xywav 500MG/ML oral soln (36C26026F0146), from Veterans Integrated Service Network 20 (VHA), on February 1, 2026.
On GovTribe
See Jazz Pharmaceuticals, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors